HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps
P Prakash, BS Swami Vetha, R Chakraborty… - Circulation …, 2024 - Am Heart Assoc
HIV type 1 (HIV-1) is the causative agent of AIDS. Since the start of the epidemic, HIV/AIDS
has been responsible for≈ 40 million deaths. Additionally, an estimated 39 million people …
has been responsible for≈ 40 million deaths. Additionally, an estimated 39 million people …
Human immunodeficiency virus and antiretroviral therapy-mediated immune cell metabolic dysregulation in children born to HIV-infected women: potential clinical …
H Mataramvura, MJ Bunders, K Duri - Frontiers in immunology, 2023 - frontiersin.org
Commencing lifelong antiretroviral therapy (ART) immediately following HIV diagnosis
(Option B+) has dramatically improved the health of HIV-infected women and their children …
(Option B+) has dramatically improved the health of HIV-infected women and their children …
Achievement of Primary Prevention Cardiometabolic Targets in Women with HIV: An Urgent Call to Action to Pursue Cardiovascular Health
Background: Cardiometabolic health has become crucial, especially for women with HIV
(WWH). We assessed the achievement of targets for hypertension, dyslipidemia, and …
(WWH). We assessed the achievement of targets for hypertension, dyslipidemia, and …
Identification of novel genetic variations in ABCB6 and GRN genes associated with HIV-associated lipodystrophy
Protease inhibitors (PIs) are associated with an incidence of lipodystrophy among people
living with HIV (PLHIV). Lipodystrophies are characterised by the loss of adipose tissue …
living with HIV (PLHIV). Lipodystrophies are characterised by the loss of adipose tissue …
A cross-sectional study of attitudes and behaviors of snuff use and cessation among people with and without HIV in South Africa
SM Loh, T Moloantoa, N Yende… - Tobacco Use …, 2023 - journals.sagepub.com
Background Despite a high (48%) prevalence of snuff use among women with HIV in South
Africa, little is known of the attitudes and behaviors of use, strategies for cessation, and …
Africa, little is known of the attitudes and behaviors of use, strategies for cessation, and …
Unveiling the Heart of the Matter: Echocardiographic Insights into Diastolic Function and Left Ventricular and Atrial Changes in HIV Patients with Controlled Viremia
M Jachymek, M Peregud-Pogorzelska… - Journal of Clinical …, 2024 - mdpi.com
Background: People living with human immunodeficiency virus (HIV)(PLWH) have
increased risk of developing diastolic dysfunction (DD) and heart failure with preserved …
increased risk of developing diastolic dysfunction (DD) and heart failure with preserved …
Hypertension Among Cohort of Persons With Human Immunodeficiency Virus Initiated on a Dolutegravir-Based Antiretroviral Regimen in Ghana
M Lartey, K Torpey, V Ganu, S Ayisi Addo… - Open forum …, 2024 - academic.oup.com
Background Dolutegravir (DTG), a new antiretroviral drug, is being integrated into
antiretroviral regimens for people with human immunodeficiency virus (PWH) in Ghana …
antiretroviral regimens for people with human immunodeficiency virus (PWH) in Ghana …
[HTML][HTML] Prevalence and Factors Associated with Hypertension among People Living with HIV Receiving Care in Three Large HIV Clinics in Nasarawa State, Nigeria
P Okonkwo, O Ajayi, D Babatunde, DM Ezekiel - World Journal of AIDS, 2024 - scirp.org
In the last decade, the long-term survival among people living with HIV (PLHIV) has
significantly improved. This is accompanied by an increased burden of non-communicable …
significantly improved. This is accompanied by an increased burden of non-communicable …
[PDF][PDF] MAJOR ARTICLE
Background: Dolutegravir, a new antiretroviral drug is being integrated into antiretroviral
regimen for PWH in Ghana. There is little evidence of the effect of dolutegravir on blood …
regimen for PWH in Ghana. There is little evidence of the effect of dolutegravir on blood …
Magnitude of Cardiovascular Diseases and Associated Factors of among Human Immune Deficiency Positive Patients on Ant-Retroviral Therapy in Ethiopia …
TY Barata, S Fentaye, B Yakob, A Abraham, M Menza… - 2024 - researchsquare.com
Background Cardiovascular disease (CVD) has been identified as the leading cause of
morbidity and mortality among people living with human immunodeficiency virus (PLHIV) …
morbidity and mortality among people living with human immunodeficiency virus (PLHIV) …